Beijing Darwin Cell Biotechnology Co., Ltd. announced the successful implementation of key steps in the divestment and transfer of the consumer healthcare segment of its business!
("we", "us", "the Company" or "Darwin Bio") divested and transferred a successful incubation from its internal technology platform [ ...]
The 2024 United Nations Civil Society Conference (2024 UNCSC) was successfully organized!
In March 2024, Darwinian biology received a letter from the Society for the Psychological Study of Social Issues (Society for the Psychological [...]).
Molecular and Cellular Neurobiology Section of the 2024 Gordon Research Conference Successfully Organized in Lucca, Italy
The Molecular and Cellular Neurobiology session of the 2024 Gordon Research Conference series was held on May 26- [...]
Darwin's Starting Point Biologic "DEW003" Opens Clinical Trial for Alzheimer's Disease Treatment
The innovative biologic agent "DEW003", developed in-house by Darwin Beginnings, is an innovative protein nanoparticle polymer that reduces the [...]
[Special announcement] on the innovative biologic drug "Alito"
Special Announcement Dear Acromegaly Patient: Based on the results of existing preclinical studies, and after the expert panel's validation and approval, our first-ever neurological repair [...]...
Newsflash｜Beijing Neuroprosthetics Industry Science and Innovation Synergy Promotion Conference was successfully held
In order to implement the "Science and Innovation China" Beijing Action Plan, to guide the deep integration of "government, industry, academia, research, application and finance", and to help the capital city's biomedical industry to develop with high quality and innovation [...]...
English 
Chinese